Which tocolytic drugs in case of preterm labor?;Menace d'accouchement prématuré: Quels tocolytiques utiliser?

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 31, Issue 7 SUPPL., 2002, Pages

  Carbonne, B ^a   Tsatsaris, V ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b Université Paris V ^*  (France)

Author keywords

Beta adrenergic agonists; Calcium channel blockers; NSAID; Oxytocin antagonists; Tocolysis

Indexed keywords

ADALATE LP20; ALVERINE CITRATE; ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MAGNESIUM SULFATE; NICARDIPINE; NIFEDIPINE; NITRIC OXIDE DONOR; OXYTOCIN ANTAGONIST; PHLOROGLUCINOL; PROGESTERONE; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; SALBUMOL; SALBUTAMOL; SPASFON; SPASMOLYTIC AGENT; UTERUS SPASMOLYTIC AGENT; ARGIPRESTOCIN; DRUG DERIVATIVE;

CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; FETUS DISEASE; HUMAN; LUNG EDEMA; MATERNAL MORTALITY; NEWBORN MORBIDITY; NEWBORN MORTALITY; PREDICTION; PREMATURE LABOR; REVIEW; SIDE EFFECT; TOCOLYSIS; FEMALE; FRANCE; PRACTICE GUIDELINE; PREGNANCY; TREATMENT OUTCOME;

CLINICAL TRIALS; FEMALE; FRANCE; HUMANS; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PRACTICE GUIDELINES; PREGNANCY; RITODRINE; TOCOLYTIC AGENTS; TREATMENT OUTCOME; VASOTOCIN;

EID: 0036857757     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Howard TE Jr, Killam AP, Penney LL, Daniell WC. A double blind randomized study of terbutaline in premature labor. MII Med 1982; 147: 305-7.
2. Ingemarsson I. Effect of terbutaline on premature labor. A double-blind placebo-controlled study. Am J Obstet Gynecol 1976; 125: 520-4.
3. Larsen JF, Hansen MK, Hesseldahl H, Kristoffersen K, Larsen PK, Osler M, Weber J, Eldon K, Lange A. Ritodrine in the treatment of preterm labour. A clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. Br J Obstet Gynaecol 1980; 87: 949-57.
4. Leveno KJ, Klein VR, Guzick DS, Young DC, Hankins GD, Williams ML. Single-centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet 1986; 1: 1293-6.
5. Merkatz IR, Peter JB, Barden TP. Ritodrine hydrochloride: A betamimetic agent for use in preterm labor. II. Evidence of efficacy. Obstet Gynecol 1980; 56: 7-12.
6. Keirse MJNC, Grant A, King JF. Preterm labour. In: Effective Care in Pregnancy and Childbirth, vol 1. Chalmers I, Enkin M and Keirse MJNC (eds) 1989. pp 694-745.
7. Hudgens DR, Conradi SE. Sudden death associated with terbutaline sulfate administration. Am J Obstet Gynecol 1993; 169: 120-1.
8. Besinger R, Iannuci T. Tocolytic Therapy. In: Elder MG, Romero R, Lamont RF, eds. New York: Churchil Livinstone, 1997, 243-97.
9. Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Med 1999; 341: 1447-57.
10. Sorkin EM, Clissold SP, Brogden RN. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs 1985; 30: 182-274.
11. Smith P, Anthony J, Johanson R. Nifedipine in pregnancy. Br J Obstet Gynaecol 2000; 107: 299-307.
12. Ulmsten U, Andersson KE, Forman A. Relaxing effects of Nifedipine on the nonpregnant human uterus in vitro and in vivo. Obstet Gynecol 1978; 52: 436-41.
13. Andersson KE, Ingemarsson I, Ulmsten U, Wingerup L. Inhibition of prostaglandin-induced uterine activity by nifedipine. Br J Obstet Gynaecol 1979; 86: 175-9.
14. Ray J. Meta-analysis of nifedipine versus beta-sympathomimetic agents for tocolysis during preterm labour. J Soc Obstet Gynaecol Can 1998; 20: 259-60.
15. Oei SG, Mol BW, de Kleine MJ, Brolmann HA. Nifedipine versus ritodrine for suppression of preterm labor; a meta-analysis. Acta Obstet Gynecol Scand 1999; 78: 783-8.
16. Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B. Tocolysis with nifedipine versus beta-mimetics. A meta-analysis. Obstet Gynecol 2001; 97: 840-7.
17. King J, Flenady V, Papatsonis D, Dekker G, Carbonne B. Calcium channe blockers for inhibiting preterm labor. Cochrane Database of Systematic Reviews. Issue 2, 2002.
18. Jannet D, Abankwa A, Guyard B, Carbonne B, Marpeau L, Milliez J. Nicardipine versus salbutamol in the treatment of premature labor. A prospective randomized study. Eur J Obstet Gynecol Reprod Biol 1997; 73: 11-6.
19. Schmitz T, Cabrol D. Tocolyse: Atosiban, un antagoniste des récepteurs de l'ocytocine. J Gynecol Obstet Biol Reprod 2001; 30: 238-45.
20. Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B, Perry KG, Varner M, Goodwin TM, Lane R, Smith J, Shangold G, Creasy GW. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000; 182: 1173-83.
21. Moutquin JM, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M, Liston RM, Dansereau J, Mazor M, Shalev E, Boucher M, Glezerman M, Zimmer EZ, Rabinovici J. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: A multicenter effectiveness and safety study. Am J Obstet Gynecol 2000; 182: 1191-9.
22. The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG 2001; 108: 133-42.
23. Blake DA, Niebyl JR, White RD, Kumor KM, Dubin NH, Robinson JC, Egner PG. Treatment of premature labor with indomethacin. Adv Prostaglandin Thromboxane Res 1980; 8: 1465-7.
24. Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin. Part II double-blind study. J Perinat Med 1984; 12: 25-9.
25. Gamissans O, Balasch J. Prostaglandin synthetase inhibitors in the treatment of preterm labor. In: Preterm Birth: Causes, Prevention and Management. Fuchs F, Stubblefield PG (eds). New York 1984, Macmillan. pp 223-248.
26. Katz Z, Lancet M, Yemini M, Mogilner BM, Feigl A, Ben Hur H. Treatment of premature labor contractions with combined ritodrine and indomethacine. Int J Gynaecol Obstet 1983; 21: 337-4.
27. Wiqvist N. Preterm labour: Other drug possibilities including drugs not to use. In: Preterm Labor. Elder MG, Hendricks CH (eds). London 1981. Butterworth. pp 148-175.
28. Gleason CA. Prostaglandins and the developing kidney. Semin Perinatol 1987; 11: 12-21.
29. Wilkinson AR. Naproxen levels in preterm infants after maternal treatment. Lancet 1980; 2: 591-2.
30. Sawdi RJ, Slater DM, Dennes WJ, Sullivan MH, Bennett PR. The roles of the cyclo-oxygenases types one and two in prostaglandin synthesis in human fetal membranes at term. Placenta 2000; 21: 54-7.
31. Takahashi Y, Roman C, Chemtob S, Tse MM, Lin E, Heymann MA, Clyman RI. Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo. Am J Physiol Regul Integr Comp Physiol 2000; 278: 1496-505.
32. Komhoff M, Wang JL, Cheng HF, Langenbach R, McKanna JA, Breyer MD. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int 2000; 57: 414-22.
33. Peruzzi L, Gianoglio B, Porcellini MG, Coppo R. Neonatal endstage renal failure associated with maternal inhibition of cyclooxygenase-type-1 selective inhibitor nimesulide as topcolytic. Lancet 1999; 354: 1615.
34. Spatling L, Spatling G. Magnesium supplementation in pregnancy. A double-blind study. Br J Obstet Gynaecol 1988; 95: 120-5.
35. Lees CC, Lojacono A, Thompson C, Danti L, Black RS, Tanzi P, White IR, Campbell S. Clyceryl trinitrate and ritodrine in tocolysis: An international multicenter randomized study. GTN Preterm Investigation Group. Obstet Gynecol 1999; 94: 403-8.
36. Black RS, Lees C, Thompson C, Pickles A, Campbell S. Maternal and fetal cardiovascular effects of transdermal glyceryl trinitrate and intravenous ritodrine. Obstet Gynecol 1999; 94: 572-6.
37. Erny R, Pigné A, Prouvost C, Gamerre M, Malet C, Serment H, Barrat J. The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol 1986; 154: 525-9.
38. Crowther CA, Moore V. Magnesium for preventing preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews. Issue 2, 2002.
39. Tsatsaris V, Carbonne B, Papatsonis D, Goffinet F. Nifedipine versus ritodrine for suppression of preterm labor; A meta-analysis. Letter. Acta Obstet Gynecol Scand 2000; 79: 618-9.
40. Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L, Hobbins J, Rayburn W, Shangold G, Wang J, Smith J, Creasy GW. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol 2000; 182: 1184-90.